Abstract
Purpose
To describe a young patient with choroidal neovascularization, associated with Stargardt’s disease, who underwent treatment with intravitreal ranibizumab.
Methods
A 26-year-old man with a diagnosis of Stargard’s disease presented at our department for sudden decreased vison in his right eye (20/800). Upon a complete oplthamologic examination, including fluorescein angiography (FA), indocyanine green angiography (ICGA) and optical coherence tomography (OCT), the patient was diagnosed with subfoveal CNV of the right eye. Owing to the subfoveal localization of the CNV, intravitreal ranibizumab injection was performed on this young patient.
Results
Three months after the last intravitreal injection of ranibizumab, fundus biomicroscopy, FA, ICGA and OCT revealed the CNV closure and total resolution of the associated cistoid macular edema and serous retinal detachment, with no recurrence and no complication from the intravitreal injection of ranibizumab. Visual acuity improved only to 20/400.
Conclusion
Intravitreal ranibizumab injection seems to induce total regression of CNV complicating Stargardt’s disease. Further investigations are required to confirm our results.
Similar content being viewed by others
References
Stargardt K (1909) Ueber familiare progressive Degeneration in der Makulagegend des Auges. Albrecht Von Graefes Arch Ophthalmol 71:534–50
Cibis GW, Morey M, Karris DJ (1980) Dominantly inherited macular dystrophy with flecks (Stargardt). Arch Ophthalmol 98:1785
Merlin S, Landau J (1970) Abnormal findings in relatives of patients with juvenile hereditary macular degeneration (Stargardt’s disease). Ophthalmologica 161:1
Allikmets R, Singh N, Sun H et al (1997) A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15:236–46
Cremers FP, van de Pol DJ, van Driel M et al (1998) Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt’s disease gene ABCR. Hum Mol Genet 7:355–62
Rozet JM, Gerber S, Souied E et al (1998) Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies. Eur J Hum Genet 6:291–5
Klein R, Lewis RA, Meyers SM, Myers FL (1978) Subretinal neovascularization associated with fundus flavimaculatus. Arch Ophthalmol 96:2054–2057
Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431
Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444
Souied EH, Pawlak D, Algan M et al (2005) Photodynamic therapy for choroidal neovascularization on late-onset fundus flavimaculatus. Am J Ophthalmol 140:312–4
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no proprietary interest in the materials used in this study.
Rights and permissions
About this article
Cite this article
Querques, G., Bocco, M.C.A., Soubrane, G. et al. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with Stargardt’s disease. Graefes Arch Clin Exp Ophthalmol 246, 319–321 (2008). https://doi.org/10.1007/s00417-007-0689-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-007-0689-z